Basic Semaglutide Information INN (International Nonproprietary Name): Semaglutide Brand Names Available in Canada: Ozempic, Wegovy, Rybelsus ATC Code: A10BJ06 Forms & Dosages: Subcutaneous injection: 0.25mg, 0.5mg, 1mg, 1.7mg, 2mg, 2.4mg Oral tablet: 3mg, 7mg, 14mg Manufacturers in Canada: Novo Nordisk Registration Status in Canada: Approved OTC/Rx Classification: Prescription-only (Rx) Understanding Semaglutide and Its Brand Names Semaglutide is a significant medication in managing diabetes and obesity
It attaches to and activates the same receptor that the body's natural GLP-1 hormone uses, found in the pancreas, brain, and gut
Monitoring prescribing trends and shortages: Truvetas daily-updated data allows for the monitoring of GLP-1 prescribing trends, helping researchers identify shifts in practice, as well as potential shortages of medications
Therefore, glucose concentrations found within the majority of the brain in vivo under physiological and pathophysiological conditions are within the 0.2 to 5 mM range [73-76], and it seems that the GE and GI neurons are mainly responsible for glucose sensing, since it is unclear whether brain glucose levels ever exceed 5 mM in the presence of an intact blood brain barrier
While this review focused primarily on adult populations, there is limited research available on the use of GLP-1 therapies in pediatric patients